Adam is Dolon’s Managing Partner and heads up our US Office. A health economist by training, he has 25 years of global pricing and market access experience in consulting and the pharmaceutical industry, including roles at Aventis, GlaxoSmithKline and Baxter Healthcare. He is an expert in healthcare policy relating to pricing, reimbursement, and patient access to medicines for rare diseases and oncology.
Featured
Prescient Intelligence
Discover our portfolio of AI-powered assessments and intelligent tools designed to support better strategic decisions.
News and insights
Featured
Strategy that learns: Rethinking brand planning for a changing environment
Explore why the strongest brand strategies continue beyond annual planning.
Discover The Prescient Pharma Brand Plan Impact Index
Helping senior leaders strengthen strategy and drive better business performance.
The Four Positioning Challenges Every Pharma Launch Team Must Overcome
Discover four positioning challenges that every pharma launch team should address.
Careers
Work with us
If you're looking to stretch your thinking, lead with purpose, and be part of a culture that values curiosity, accountability and trust, you're in the right place.
